ATE281837T1 - Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation - Google Patents

Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation

Info

Publication number: ATE281837T1
Authority: AT; Austria
Prior art keywords: diphosphates; uthydration; muccus; adenine; promoting
Prior art date: 1999-02-26

Application number

AT00914781T

Other languages

English (en)

Inventor

Benjamin R Yerxa

Janet L Rideout

Arthur C Jones

Original Assignee

Inspire Pharmaceuticals

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-26

Filing date

2000-02-25

Publication date

2004-11-15

2000-02-25 Application filed by Inspire Pharmaceuticals filed Critical Inspire Pharmaceuticals

2004-11-15 Application granted granted Critical

2004-11-15 Publication of ATE281837T1 publication Critical patent/ATE281837T1/de

Links

239000001177 diphosphate Substances 0.000 title 2
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 title 2
235000011180 diphosphates Nutrition 0.000 title 2
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 title 1
229930024421 Adenine Natural products 0.000 title 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 title 1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 title 1
229960000643 adenine Drugs 0.000 title 1
UHDGCWIWMRVCDJ-XVFCMESISA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-XVFCMESISA-N 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
230000001737 promoting effect Effects 0.000 title 1
239000001226 triphosphate Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Gynecology & Obstetrics (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT00914781T 1999-02-26 2000-02-25 Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation ATE281837T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12175499P	1999-02-26	1999-02-26
PCT/US2000/005282 WO2000050024A2 (en)	1999-02-26	2000-02-25	Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof

Publications (1)

Publication Number	Publication Date
ATE281837T1 true ATE281837T1 (de)	2004-11-15

Family

ID=22398588

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00914781T ATE281837T1 (de)	1999-02-26	2000-02-25	Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation

Country Status (12)

Country	Link
US (2)	US6331529B1 (de)
EP (1)	EP1161246B1 (de)
JP (1)	JP2002537329A (de)
KR (1)	KR20010114214A (de)
AR (1)	AR023088A1 (de)
AT (1)	ATE281837T1 (de)
AU (1)	AU3612600A (de)
BR (1)	BR0008498A (de)
CA (1)	CA2359891A1 (de)
DE (1)	DE60015734D1 (de)
MX (1)	MXPA01008547A (de)
WO (1)	WO2000050024A2 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6319908B1 (en)	1996-07-03	2001-11-20	Inspire Pharmaceuticals, Inc.	Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en)	1996-07-23	2002-05-07	Inspire Pharmaceuticals	Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
TW593331B (en)	1997-07-25	2004-06-21	Inspire Pharmaceuticals Inc	Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
US6872710B2 (en)	1997-07-25	2005-03-29	Inspire Pharmaceuticals, Inc.	Di(uridine 5′)-tetraphosphate and salts thereof
CA2295515C (en)	1997-07-25	2006-03-14	Inspire Pharmaceuticals, Inc.	Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
US6432454B1 (en) *	1997-12-12	2002-08-13	C. V. Technologies, Inc.	Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
MXPA01008547A (es)	1999-02-26	2003-06-06	Inspire Pharmaceuticals Inc	Metodo para promover la hidratacion de mucosas con ciertos difosfatos de uridina, adenina y citidina, y analogos de estos.
US6624150B2 (en)	1999-02-26	2003-09-23	Inspire Pharmaceuticals, Inc.	Method of treating gastrointestinal tract disease with purinergic receptor agonists
US20020061281A1 (en) *	1999-07-06	2002-05-23	Osbakken Robert S.	Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en)	1999-07-06	2003-06-10	Sinuspharma, Inc.	Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
CN1413113A (zh) *	1999-12-22	2003-04-23	印斯拜尔药品股份有限公司	使用嘌呤能受体激动剂治疗胃肠道疾病的方法
US6864243B1 (en)	2000-05-12	2005-03-08	Inspire Pharmaceuticals, Inc.	Method for treating retinal degeneration with purinergic receptor agonists
AU2001260643B9 (en) *	2000-05-30	2006-10-19	Merck Sharp & Dohme Corp.	Ectocornea extension promoters
US6555675B2 (en)	2000-08-21	2003-04-29	Inspire Pharmaceuticals, Inc.	Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
US7452870B2 (en)	2000-08-21	2008-11-18	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7018985B1 (en)	2000-08-21	2006-03-28	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
US7132408B2 (en)	2000-08-21	2006-11-07	Inspire Pharmaceuticals, Inc.	Composition and method for inhibiting platelet aggregation
US6867199B2 (en)	2000-08-21	2005-03-15	Inspire Pharmaceuticals, Inc.	Dinucleoside polyphosphate compositions and their therapeutic use
AR034635A1 (es)	2001-06-25	2004-03-03	Inspire Pharmaceuticals Inc	Lubricacion de las articulaciones con agonistas del receptor purinergico p2y
KR20050043761A (ko)	2001-11-06	2005-05-11	인스파이어 파마슈티컬스 인코퍼레이티드	염증성 질환의 치료 또는 예방 방법
US6858615B2 (en)	2002-02-19	2005-02-22	Parion Sciences, Inc.	Phenyl guanidine sodium channel blockers
US7179481B2 (en) *	2002-09-19	2007-02-20	Kimberly-Clark Worldwide, Inc.	Vaginal health products
MXPA05004121A (es) *	2002-10-18	2006-02-17	Molichem Medicines Inc	Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
US7056889B2 (en)	2002-12-16	2006-06-06	Kimberly-Clark, Worldwide, Inc.	Compounds that bind P2Y2 or P2Y1 receptors
US6984628B2 (en) *	2003-07-15	2006-01-10	Allergan, Inc.	Ophthalmic compositions comprising trefoil factor family peptides
AU2004264441A1 (en) *	2003-08-18	2005-02-24	Parion Sciences, Inc.	Cyclic pyrazinoylguanidine sodium channel blockers
US7326683B2 (en) *	2004-05-06	2008-02-05	Molichem Medicines, Inc.	Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
US7479481B2 (en) *	2004-05-06	2009-01-20	Molichem Medicines, Inc.	Treatment of ocular diseases and disorders using lantibiotic compositions
US7368439B2 (en) *	2005-06-15	2008-05-06	Bar - Ilan University	Dinucleoside poly(borano)phosphate derivatives and uses thereof
US7851456B2 (en) *	2005-06-29	2010-12-14	Inspire Pharmaceuticals, Inc.	P2Y6 receptor agonists for treating lung diseases
US8202546B2 (en)	2005-08-04	2012-06-19	Vertical Pharmaceuticals, Inc.	Nutritional supplement for use under physiologically stressful conditions
US7901710B2 (en)	2005-08-04	2011-03-08	Vertical Pharmaceuticals, Inc.	Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en)	2005-08-04	2012-09-11	Vertical Pharmaceuticals, Inc.	Nutritional supplement for women
US7998500B2 (en)	2005-08-04	2011-08-16	Vertical Pharmaceuticals, Inc.	Nutritional supplement for women
KR100870104B1 (ko) *	2005-11-28	2008-11-26	주식회사 머젠스	안구건조증 치료 및 예방용 조성물
JP5408882B2 (ja) *	2008-01-23	2014-02-05	ヤマサ醤油株式会社	唾液分泌促進剤
AR086745A1 (es)	2011-06-27	2014-01-22	Parion Sciences Inc	3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
MX2015007797A (es)	2012-12-17	2015-10-05	Parion Sciences Inc	Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
PE20151054A1 (es)	2012-12-17	2015-08-07	Parion Sciences Inc	Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales
US9102633B2 (en)	2013-12-13	2015-08-11	Parion Sciences, Inc.	Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
EP3978003A1 (de)	2016-02-18	2022-04-06	Invirsa, Inc.	Medizinische verwendung von 5'-adenosindiphosphatribose (adpr)
WO2019191026A2 (en)	2018-03-27	2019-10-03	Invirsa, Inc.	Methods for the use of 5'-adenosine diphosphate ribose (adpr)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4753945A (en)	1986-02-19	1988-06-28	Eye Research Institute Of Retina Foundation	Stimulation of tear secretion with phosphodiesterase inhibitors
US4868154A (en)	1986-02-19	1989-09-19	Eye Research Institute Of Retina Foundation	Stimulation of tear secretion with melanocyte stimulating hormones
US5635160A (en) *	1995-06-07	1997-06-03	The University Of North Carolina At Chapel Hill	Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5628984A (en)	1995-07-31	1997-05-13	University Of North Carolina At Chapel Hill	Method of detecting lung disease
US5900407A (en) *	1997-02-06	1999-05-04	Inspire Pharmaceuticals, Inc.	Method of treating dry eye disease with uridine triphosphates and related compounds
US5789391A (en)	1996-07-03	1998-08-04	Inspire Pharmaceuticals, Inc.	Method of treating sinusitis with uridine triphosphates and related compounds
US6159952A (en) *	1996-11-07	2000-12-12	Inspire Pharmaceuticals, Inc.	Method of treating bronchitis with uridine triphosphate and related compounds
WO1998034942A2 (en)	1997-02-06	1998-08-13	Inspire Pharmaceuticals, Inc.	Dinucleotides and their use
CA2300146A1 (en) *	1997-08-29	1999-03-04	Richard C. Boucher, Jr.	Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
MXPA01008547A (es)	1999-02-26	2003-06-06	Inspire Pharmaceuticals Inc	Metodo para promover la hidratacion de mucosas con ciertos difosfatos de uridina, adenina y citidina, y analogos de estos.

2000
- 2000-02-25 MX MXPA01008547A patent/MXPA01008547A/es unknown
- 2000-02-25 AR ARP000100810A patent/AR023088A1/es unknown
- 2000-02-25 JP JP2000600636A patent/JP2002537329A/ja active Pending
- 2000-02-25 WO PCT/US2000/005282 patent/WO2000050024A2/en not_active Ceased
- 2000-02-25 AU AU36126/00A patent/AU3612600A/en not_active Abandoned
- 2000-02-25 DE DE60015734T patent/DE60015734D1/de not_active Expired - Lifetime
- 2000-02-25 US US09/512,867 patent/US6331529B1/en not_active Expired - Fee Related
- 2000-02-25 CA CA002359891A patent/CA2359891A1/en not_active Abandoned
- 2000-02-25 AT AT00914781T patent/ATE281837T1/de not_active IP Right Cessation
- 2000-02-25 BR BR0008498-0A patent/BR0008498A/pt not_active Application Discontinuation
- 2000-02-25 EP EP00914781A patent/EP1161246B1/de not_active Expired - Lifetime
- 2000-02-25 KR KR1020017010900A patent/KR20010114214A/ko not_active Withdrawn
2001
- 2001-12-03 US US10/005,267 patent/US6436910B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AR023088A1 (es)	2002-09-04
CA2359891A1 (en)	2000-08-31
US6331529B1 (en)	2001-12-18
EP1161246A2 (de)	2001-12-12
MXPA01008547A (es)	2003-06-06
US6436910B1 (en)	2002-08-20
KR20010114214A (ko)	2001-12-31
DE60015734D1 (de)	2004-12-16
BR0008498A (pt)	2002-02-05
EP1161246B1 (de)	2004-11-10
AU3612600A (en)	2000-09-14
WO2000050024A3 (en)	2001-07-05
JP2002537329A (ja)	2002-11-05
WO2000050024A2 (en)	2000-08-31
US20020052338A1 (en)	2002-05-02

Legal Events

Date	Code	Title	Description
2005-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60015734D1 (de)	2004-12-16	Verwendung von dinukleotidtriphosphaten, cytidindiphosphaten und adenindiphosphaten zur herstellung einer pharmazeutischen zubereitung zur förderung der schleimauthydratation
DE3765045D1 (de)	1990-10-25	Fluorierte nucleoside, ihre herstellung und ihre pharmazeutische verwendung gegen aids.
DE3674906D1 (de)	1990-11-15	Selbstklemmende medizinische prothese und ihre herstellung.
DE68905939D1 (de)	1993-05-19	Infektionsresistente zusammensetzungen, medizinische geraete und oberflaechen und verfahren zur herstellung und gebrauch derselben.
ATE383424T1 (de)	2008-01-15	Polypeptide, deren herstellung und verwendung
ATE248599T1 (de)	2003-09-15	Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen
DE69015509D1 (de)	1995-02-09	Aluminiumoxidkeramik, ihre herstellung und wegwerfstück daraus.
DE60002526D1 (de)	2003-06-12	Herstellung von Tricyclodecandicarbaldehyd, Pentacyclopentadecandicarbaldehyd und der entsprechenden Dimethanole
DE3680578D1 (de)	1991-09-05	Dipeptid-derivate, verfahren zur herstellung, pharmazeutische zusammensetzungen und ihre anwendung.
DE3885534D1 (de)	1993-12-16	Arylphosphorderivate, ihre Herstellung und Verwendung.
ATE327257T1 (de)	2006-06-15	Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
DE59905572D1 (de)	2003-06-18	Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
DE3877406D1 (de)	1993-02-25	Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
ATE288273T1 (de)	2005-02-15	Verwendung von uridin-5'-diphosphat und analoge zur behandlung von lungenerkrankungen
DE60227718D1 (de)	2008-08-28	Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
ATE100098T1 (de)	1994-01-15	Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
ATE73762T1 (de)	1992-04-15	N-aminobutyl-n-phenylarylamid-derivate, ihre herstellung und ihre verwendung in der heilkunde.
ATE74487T1 (de)	1992-04-15	Verfahren zur herstellung und verwendung fester, pflanzenwirksamer zusammensetzungen.
DE69901243D1 (de)	2002-05-16	Artikulator zur herstellung von zahnärztlichen prothesen
DE3769358D1 (de)	1991-05-23	1-acyl-2,3-dihydro-4(1h)-chinolinon-4-oxim-derivate, verfahren zur herstellung davon, pharmazeutische zusammensetzungen und zwischenprodukte.
AU3609800A (en)	2000-09-14	Novel formulations of alkyllithiums with improved thermal stability, processes to produce these formulations and processes for using the same to improve stability of living polymer chain ends
ATE79371T1 (de)	1992-08-15	Derivate des cysteins, verfahren zur herstellung und verwendung davon.
IT1313660B1 (it)	2002-09-09	Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani.
DE69801454D1 (de)	2001-10-04	Verfahren zur Herstellung von 2-Methyl-1,4-Benzochinon
EE04749B1 (et)	2006-12-15	Parendatud omadustega bensoüülguanidiini derivaadid, meetod nende valmistamiseks ja nende kasutamine ravimite valmistamiseks